Month: January 2017
-
News Blackout Imposed on U.S. Science Agencies [Updated]
Multiple news services today are reporting that the Trump administration is ordering several U.S. government agencies conducting or funding scientific research to cease discussing its activities with the media or public officials.
-
Neuro Device Company to Begin Clinical Trials in Europe
Clinical trials in Europe are set to begin to test a non-invasive device that stimulates nerves and the spinal cord to treat neuromotor disorders.
-
Biopharm, Hospital to Partner on Cell Energy Diseases
A biopharmaceutical company in Sweden and children’s hospital in the U.S. are collaborating on research into deficiencies in cells’ energy components responsible for a number of genetic disorders.
-
Safer Engineered-Cell Cancer Immunotherapy Designed
A biotechnology company designed a new type of engineered T-cell from the immune system that more precisely targets tumors and stays away from healthy cells.
-
FDA Begins Cancer Product Review Center
The U.S. Food and Drug Administration is reorganizing its review of treatments for cancer into a structure that cuts across its traditional bureaucratic lines.
-
Lilly Acquires Migraine Therapy Company in $960M Deal
Drug maker Eli Lilly and Company is acquiring CoLucid Pharmaceuticals, a developer of treatments for migraine pain and associated symptoms.
-
UC San Francisco, Intel Partner on Health Analytics
Intel Corporation and University of California in San Francisco are developing a data analytics platform that harnesses artificial intelligence to help front-line clinicians make better decisions for their patients.
-
California Set to Pioneer Blockchain ATMs in MMJ Dispensaries Statewide
California will see a new form of blockchain cryptocurrency POS terminals in key medical marijuana dispensaries around the state.
-
Pharma Firms Start Non-Communicable Disease Initiative
A group of 22 pharmaceutical companies is supporting worldwide projects to improve access to prevention and treatments for chronic disorders like cancer and heart disease, in lower-resource regions.
-
Mobile App Designed to Study Rare Inflammatory Condition
Researchers at University of Pennsylvania medical school developed an iPhone app to study sarcoidosis, a rare inflammatory disease where the cause is still unknown.